The regulatory status of xylazine for use in food-producing animals in the United States

Journal of Veterinary Pharmacology and Therapeutics

Volumn 21, Issue 4, 1998, Pages 322-329

  Chamberlain, P L ^a   Brynes, S D ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DIMETHYLANILINE; DRUG METABOLITE; UNCLASSIFIED DRUG; XYLAZINE;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL CARCINOGENESIS; DRUG APPROVAL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG LEGISLATION; DRUG TRANSFORMATION; GENOTOXICITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TERATOGENICITY; TRANQUILIZING ACTIVITY; UNITED STATES; VETERINARY MEDICINE;

ADRENERGIC ALPHA-AGONISTS; ANILINE COMPOUNDS; ANIMALS; CARCINOGENICITY TESTS; CATTLE; DRUG APPROVAL; DRUG RESIDUES; FOOD CONTAMINATION; MEAT PRODUCTS; MILK; RATS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; XYLAZINE;

ANIMALIA; APOGON BRACHYGRAMMUS; BOS TAURUS; CERVIDAE;

EID: 0031927510     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.1998.00140.x     Document Type: Article

References (44)

1. Bayer, A.G. (1967) Anaesthetic, analgesic and sedative for veterinary medicine. Unpublished report No. 23074, Bayer Ag. Leverkusen, Germany.
2. Bayer, A.G. (1968a) The effect of large injected doses of Bay Va 1470 to dogs. Unpublished report no. 23679, Bayer AG. Leverkusen, Germany.
3. Bayer, A.G. (1968b) A study of the effect of large doses of Bay Va 1470 to horses. Unpublished report No. 23405, Bayer AG, Leverkusen, Germany.
4. Bayer, A.G. (1968c) Experimental tests on animals with radioactive labeled BAY Va 1470. Unpublished report No. 22874, Bayer AG, Leverkusen, Germany.
5. Bayer, A.G. (1969a) Toxicity of BAY Va 1470 to cats. Unpublished report No. 24208, Bayer AG. Leverkusen, Germany.
6. Bayer, A.G. (1969b) Subehronic toxicity for dogs during application as feed additive. Unpublished report No. 26692, Bayer AG, Leverkusen, Germany.
7. Bayer, A.G. (1970) Pathology report of the subchronic toxicity for dogs by oral administration of compond BAY Va 1470. Unpublished report No. 26692, Bayer AG, Leverkusen, Germany.
8. Bayer, A.G. (1975a) Residues of "ROMPUN and its metabolites in cattle. Unpublished report No. 45814, Bayer AG, Leverkusen, Germany.
9. Bayer, A.G. (1975b) Residues of "ROMPUN and its metabolites in cattle. IL Unpublished report No. 70345, Bayer AG, Leverkusen, Germany.
10. Bayer, A.G. (1975c) Development of an analytical method for determination of 2,6-dimethylaniline in bovine liver, Unpublished report No. 54940, Bayer AG, Leverkusen, Germany.
11. Bayer, A.G. (1975d) Hydrolysis studies on liver from bovine treated with "ROMPUN. Unpublished report No. 54943, Bayer AG, Leverkusen, Germany.
12. Bayer, A.G. (1975e) Analysis of liver for DMA from "ROMPUN treated cattle. Unpublished report No. 54944, Bayer AG, Leverkusen, Germany.
13. Bayer, A.G. (1975f) Basic hydrolysis studies on liver from bovine treated with "ROMPUN. Unpublished report No. 54945, Bayer AG, Leverkusen, Germany.
14. Bayer, A.G. (1984) Salmonella/microsome test to evaluate for point-mutagenic effects. Unpublished report No. T0016805, Bayer AG, Leverkusen, Germany.
15. Bayer, A.G. (1994a) Teratology study in the rat. Unpublished report No. 94/BAG240/0268, Bayer AG, Leverkusen, Germany.
16. Bayer, A.G. (1994b) Rompun hydrochloride. Mutagenicity study for the detection of induced forward mutations in the V79-HGPRT assay in vitro. Unpublished report No. T9049349, Bayer AG, Leverkusen, Germany.
17. Bayer, A.G. (1995) Rompun hydrochloride. Micronucleus test on the mouse. Unpublished report No. T9058169 + T2058171, Bayer AG, Leverkusen, Germany.
18. Brown, J.R. (1986) Use of xylazine in cattle. Modern Veterinary Practice, 67, 125-126.
19. Florin, I., Rutberg, L., Curvall, M. & Enzell, C.R. (1980) Screening of tobacco smoke constituents for mutagenicity using the Ames' test. Toxicology, 15, 219-232.
20. Food and Agriculture Organisation (FAO) (1997) Xylazine. Residues of some veterinary drugs in animals and foods. FAO Food and Nutrition Paper, No. 41/9, pp. 119-125.
21. Galloway, S.M.., Armstrong, M.J., Reuben, C., Colman, S., Brown, B., Cannon, C., Bloom, A.D., Nakamura, F., Ahmed, N., Duk, S., Rimpo, J., Margolin, B.H., Resnick, M.A., Anderson, B. & Zeiger, E. (1987) Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environmental and Molecular Mutagenesis, 10, 1-175.
22. Garcia-Villar, R., Toutain, P.L., Alvinerie, M. & Ruckebusch, Y. (1981) The pharmacokinetics of xylazine hydrochloride: an interspecific study. Journal of Veterinary Pharmacology and Therapeutics, 4, 87-92.
23. Grubb, T.L., Riebold, T.W., & Huber, M.J. (1993) Evaluation of lidocaine, xylazine, and a combination of lidocaine and xylazine for epidural analgesia in Ilamas. Journal of the American Veterinary Medical Association, 203, 1441-1444.
24. International Agency for Research on Cancer (IARC) (1993) 2,6-Dimethylaniline (2,6-xylidine). In Monographs on the Evaluation of Carcinogenic Risks to humans. International Agency for Research on Cancer; Lyon, France, 57, 323-335.
25. Jacobson, K.H. (1972) Short communication. Acute oral toxicity of mono- and di-alkyl ring-substituted derivatives of aniline. Toxicology and Applied Pharmicology, 22, 153-154.
26. Keukens, H.J. & Aerts, M.M.L. (1989) Determination of residues of carazolol and a number of tranquilzers in swine kidney by high performance liquid chromatography with ultraviolet and fluorescence detection. Journal of Chromatography, 464, 149-161.
27. Kugler-Steigmeier, M.E., Frierich, U., Graf, U. Lutz, W.K., Maier, P. & Schlatter, C. (1989) Genotoxicity of aniline derivatives in various short-term tests. Mutation Research 211, 279-289.
28. Lindstrom, H.V., Hansen, W.H., Nelson, A.A. & Fitzhugh, O.G (1963) The metabolism of FD & C Red No. 1 Il. The fate of 2,5-para-xylidine and 2,6-meta-xylidine in rats and observations of the toxicity of xylidine isomers. Journal of Pharmacology and Experimental Therapeutics, 142, 257-264.
29. Lindstrom, H.V., Bowie, W.C., Wallace, W.C., Nelson, A.A. & Fitzhugh. O.G. (1969) The toxicity and metabolism of mesidine and pseudocumidine in rats. Journal of Pharmacology and Experimental Therapeutics, 167, 223-234.
30. Magnusson, G., Bodin, N.-O. & Hansson, E. (1971) Hepatic changes in dogs and rats induced by xylidine isomers. Acta Pathologica et Microbiologica Scandinavia, section A, 79, 639-648.
31. Mirsalis, J.C., Tyson, C.K., Steinmetz, K.L., Loh, E.K., Hamilton, C.M., Bakke, J.P. & Splading, J.W. (1989) Measurement of unscheduled DNA synthesis and S-phase synthesis in rodent hepatocytes following in vivo treatment: testing of 24 compounds. Environmental and Molecular Mutagenesis, 13, 155-164.
32. Mutlib, A.E., Chui, Y.C., Young, L.M. & Abbott, F.S. (1992) Characterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS. Drug Metabolism and Disposition, 20, 840-848.
33. Parton, J.W., Probst, G.S. & Garriott, M.L. (1988) The in vivo effects of 2,6-xylidine on induction of micronuclei in mouse bone marrow cells. Mutation Research 206, 281-283.
34. Parton, J.W., Beyers, J.E., Gerriott, M.L. & Tamura, R.N. (1990) The evaluation of multiple dosing protocol for the mouse bone-marrow micronucleus assay using benzidine and 2,6-xylidine. Mutation Research, 234, 165-168.
35. Putter, J. & Sanger, G. (1973) Chemical studies to detect residues of xylazine hydrochloride. Veterinary Medicine Reviews, 2, 145-159.
36. Riebold, T.W., Goble, D.O. & Geisser, D.R. (1982) Large Animal Anesthesia Principles and Techniques. Eds Riebold, T.W., Goble, D.O., Geiser, D.R. pp. 11-12; 80-82.Iowa State University Press, Ames, Iowa.
37. Rudd, C.J., Mitchell, A.D. & Spalding, J. (1983) L5178Y Mouse lymphoma cell mutagenesis assay of coded chemicals incorporating analyses of the colony size distributions (Abstract No. Cd-19). Environmental Mutagenesis, 5, 419
38. Short, C.R., King, C., Sistrunk, P.W. & Kerr, K.M. (1983) Subacute toxicity of several ring-substituted dialkylanilines in the rat. Fundamental and Applied Toxicology, 3, 285-292.
39. 14C]-2,4-dimethylaniline to DNA of rat liver and ethmoid turbinate. Journal of Toxicology and Environmental Health, 27, 85-89.
40. Turner, S.A. & McIlwraith, C.W. (1982) Techniques in Large Animal Surgery. Eds Turner, S.A. & McIlwraith, C.W. pp. 18-19. Lea & Febiger, Philadelphia, PA.
41. US National Toxicology Program (1990) Toxicology and carcinogenesis Studies of 2,6-Xylidine (2,6-Dimethylaniline) (CAS No. 87-62-7) in Charles River CD Rats (Feed Studies). NTP Technical Report No. 278: NIH Publication No. 90-2534, Research Triangle Park, North Carolina.
42. Vernot, E.H., MacEwen, J.D., Haun, C.C. & Kinkead, E.R. (1977) Acute toxicity and skin corrosion data for some organic and inorganic compounds and aqueous solutions. Toxicology and Applied Pharmacology, 42, 417-4-23.
43. World Health Organisation (WHO) (1996) Xylazine. WHO Food Additive Series 38. pp. 45-75. International Programme on Chemical Safety, Geneva, Switzerland.
44. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T. & Mortelmans, K. (1988) Salmonella mutagenicity test: IV. Results from the testing of 300 chemicals. Environmental and Molecular Mutagenesis, 11. 1-158.